Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans.

@article{Sculean2002ClinicalEO,
  title={Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans.},
  author={Anton Sculean and Giovanni Carlo Chiantella and P{\'e}ter Windisch and Istv{\'a}n Gera and Elmar Reich},
  journal={The International journal of periodontics & restorative dentistry},
  year={2002},
  volume={22 3},
  pages={259-67}
}
The purpose of the present study was to compare the treatment of deep intrabony defects with a combination of an enamel matrix protein derivative (EMD; Emdogain) and a bovine-derived xenograft (BDX; Bio-Oss) to BDX alone. Twenty-four healthy patients, each of whom displayed one intrabony defect, were randomly treated with a combination of EMD + BDX (test… CONTINUE READING